BSX vs INSP
BSX: Boston Scientific is a leading medical device company dedicated to transforming lives through innovative, less-invasive medical solutions for a broad range of interventional specialties. INSP: Inspire Medical Systems provides a unique, neurostimulation-based alternative therapy for obstructive sleep apnea patients who struggle with traditional PAP machines.
Side-by-side fundamentals
| Metric | BSX | INSP | Edge |
|---|---|---|---|
| Price as of 2026-08-04 close | $49.09 | $64.14 | |
| Market cap as of 2026-08-05 | $71.1B | $1.8B | |
| P/E as of 2026-08-05 | 19.66 | 13.94 | INSP lower |
| PEG as of 2026-08-05 | 0.42 | 0.07 | INSP lower |
| Net margin as of 2026-08-05 | +17.5% | +14.3% | BSX higher |
| Gross margin as of 2026-08-05 | +69.8% | +85.8% | INSP higher |
| Operating margin as of 2026-08-05 | +19.8% | +5.2% | BSX higher |
| ROE as of 2026-08-05 | +14.9% | +18.0% | INSP higher |
| ROA as of 2026-08-05 | +8.3% | +15.3% | INSP higher |
| Debt / equity as of 2026-08-05 | 0.43 | 0.00 | INSP lower |
| Revenue growth (YoY) as of 2026-08-05 | +13.5% | +8.9% | BSX higher |
| Revenue CAGR (3y) SEC XBRL | +16.5% | +30.8% | INSP higher |
| Dividend yield | n/a | n/a | |
| Beta as of 2026-08-05 | 0.57 | 0.71 | |
| 1-year return as of 2026-08-04 close | -54.0% | -50.6% | INSP higher |
Fundamentals: market data, as of 2026-08-05. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-04.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.